Showing results (101-110 of 146) with videos related to
Sort By:
Pageof 15
Melanoma Research|August 4, 2015
Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanomaAkira Shimizu, Kyoichi Kaira, Madoka Kato, et al.Annals of Nuclear Medicine|May 5, 2009
Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivityHirofumi Hanaoka, Toyomasa Katagiri, Chikako Fukukawa, et al.Journal of Surgical Oncology|April 7, 2009
L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomasKyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al.Anticancer Research|November 24, 2011
Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrenceKyoichi Kaira, Toshiaki Takahashi, Haruyasu Murakami, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 18, 2011
Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancerHaruhiko Imamoto, Koji Oba, Junichi Sakamoto, et al.Health Physics|February 5, 2020
Determination of the Kinetic Parameters for 123I Uptake by the Thyroid, Thyroid Weights, and Thyroid Volumes in Present-day Healthy Japanese VolunteersTakashi Kudo, Akihiro Inano, Sanae Midorikawa, et al.Cancer Science|December 11, 2008
Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lungKyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al.Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 14, 2009
[Assessment for the image interpretation of 111In-ibritumomab tiuxetan in the phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma]Noboru Oriuchi, Kiyoshi Koizumi, Mitsuru Koizumi, et al.Annals of Surgical Oncology|September 25, 2009
CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastasesKyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al.Experimental and Therapeutic Medicine|September 21, 2012
Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancerKyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al.Pageof 15